Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 10:30 a.m. ET. The event will be available under the Investors tab on their website and archived for 14 days. Alkermes is a global biopharmaceutical company focused on developing innovative medicines for neuroscience and oncology, with a portfolio addressing addiction, schizophrenia, and bipolar I disorder.

Positive

• Participation in a high-profile global healthcare conference, which may increase visibility and investor interest.
• The company has a diverse product portfolio focused on critical mental health issues, indicating potential for strong market demand.

Negative

• None.

DUBLIN, June 3, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the Goldman Sachs 42^nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 10:30 a.m. ET (3:30 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-goldman-sachs-annual-global-healthcare-conference-301305712.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Goldman Sachs Annual Global Healthcare Conference?

Alkermes will participate on June 9, 2021, at 10:30 a.m. ET.

Where can I access Alkermes' presentation from the conference?

The presentation will be available under the Investors tab on Alkermes' website.

What is Alkermes' focus as a biopharmaceutical company?

Alkermes focuses on developing innovative medicines in neuroscience and oncology.

How long will Alkermes' presentation be archived for viewing?

The presentation will be archived for 14 days.